Estrogen and testosterone are cardioprotective. The Women's Health Initiative study, which condemned hormone replacement therapy, used synthetic progestins — not natural progesterone — and its adverse findings do not apply to bioidentical hormone replacement.

The WHI Mistake

The Women's Health Initiative (WHI) study, published in 2002, found that hormone replacement therapy increased the risk of breast cancer, cardiovascular disease, and stroke. This finding caused millions of women to stop taking HRT, and many physicians stopped prescribing it.

The problem: the WHI used synthetic hormones — conjugated equine estrogens (Premarin) and medroxyprogesterone acetate (Provera) — not natural human hormones. The adverse effects found in the WHI are specific to these synthetic hormones and do not apply to bioidentical hormone replacement therapy (BHRT).

Natural Estrogen Is Cardioprotective

The evidence that natural estrogen is cardioprotective is strong:

  • Premenopausal women have much lower rates of cardiovascular disease than men of the same age
  • After menopause, women's cardiovascular risk rises to equal men's
  • Observational studies of women using bioidentical estradiol show reduced cardiovascular risk
  • Estrogen improves lipid profiles, reduces inflammation, and improves endothelial function

The Women's Health Initiative used synthetic progestins, not natural progesterone. The adverse findings do not apply to bioidentical hormone replacement therapy.

Natural Progesterone vs. Synthetic Progestins

Natural progesterone and synthetic progestins have very different effects:

Natural progesterone:

  • Cardioprotective
  • Does not increase breast cancer risk (may reduce it)
  • Improves sleep
  • Reduces anxiety

Synthetic progestins (medroxyprogesterone acetate):

  • Cardiovascular risk
  • Increases breast cancer risk
  • Disrupts sleep
  • Causes mood disturbances

The WHI used medroxyprogesterone acetate. The adverse cardiovascular and cancer findings are specific to this synthetic progestin.

Testosterone Is Also Cardioprotective

Testosterone is cardioprotective in both men and women:

  • Low testosterone is associated with increased cardiovascular risk in men
  • Testosterone replacement therapy in hypogonadal men improves cardiovascular risk factors
  • Testosterone improves insulin sensitivity, reduces visceral fat, and improves endothelial function

The French Cohort Study

The E3N French cohort study, which followed 80,000 women for 8 years, found that women using natural progesterone (not synthetic progestins) had no increased risk of breast cancer, while women using synthetic progestins had significantly increased risk. This is the key study that distinguishes natural from synthetic hormones.